Logo image
Low level of systemic autoimmunity in Western Australian multiple sclerosis patients
Journal article   Peer reviewed

Low level of systemic autoimmunity in Western Australian multiple sclerosis patients

W. Qiu, C. Bundell, J.-S. Wu, A. Castley, I. James, P. Hollingsworth, F. Christiansen, W.M. Carroll, F.L. Mastaglia and A.G. Kermode
Multiple Sclerosis, Vol.16(3), pp.351-354
2010
url
Link to Published Version *Subscription may be requiredView

Abstract

Previous autoantibody (AAb) studies in multiple sclerosis MS have produced conflicting results. The objective of this study was to determine AAb frequency and association with the HLA-DRB1 genotype. Antinuclear antibody, antithyroid peroxidase and anti-aquaporin-4 assays and HLA-DRB1 genotyping were performed in 198 MS patients and 188 controls. There were no significant differences in AAb frequency or titres between MS and control subjects. AQP4-IgG was not found in any MS patients. There was no correlation between AAbs and HLA-DRB1 alleles. In conclusion, this study failed to confirm previous reports of increased AAbs in MS or to show an association between HLA-DRB1 genotype and the presence of AAbs.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.203 Neuromuscular Disorders
1.203.147 Multiple Sclerosis
Web Of Science research areas
Clinical Neurology
Neurosciences
ESI research areas
Neuroscience & Behavior
Logo image